We report the case of a 60-year-old man with mild Christmas disease, Factor
IX 10% of normal, who developed chronic hepatitis C infection after receiv
ing coagulation factor concentrates. Subsequently he developed encephalopat
hy and liver failure and was referred for liver transplantation. Following
transplantation, Factor IX levels rapidly normalised and have remained so,
representing a phenotypic cure of his Christmas disease.